|Articles|January 1, 1997

Managing Hypercholesterolemia and Coronary Heart Disease
Volume 3
Issue 1 Suppl

Goals and Objectives

Articles in this issue

over 29 years ago

Article

MCO Decisions and Solutions

over 29 years ago

Article

The Importance of Lipid Lowering and Other Risk Reduction Therapies

over 29 years ago

Article

Matching Risks to Interventions: When to Treat, How to Treat

over 29 years ago

Article

CME Quiz

over 29 years ago

Article

Bibliography

over 29 years ago

Article

Participants

over 29 years ago

Article

Introduction

over 29 years ago

Article

Clinical Study Outcomes and the Benefits of Treating Hypercholesterolemia

over 29 years ago

Article

Goals for Patient Treatment

over 29 years ago

Article

Pharmacoeconomics: The Cost Effectiveness of Lipid Management

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe

Related Content

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

ByJulie A. Patterson, PharmD, PhD,Roswell A. Cole, PharmD, MPH,Jonathan D. Campbell, PhD, MS,John Michael O’Brien, PharmD, MPH

July 9th 2026

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

ByVivian T. E. Tar, PharmD, MBA

July 8th 2026

Readability of Hospital Patient Financial Policy Documents

BySamantha Randall, BA,Sumedha Raghu, MS,Ella Cho,Nina Linh Nguyen, MHA,Erin Trish, PhD,Erin L. Duffy, PhD, MPH

July 7th 2026

Goals and Objectives

Articles in this issue

Related Content

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

Readability of Hospital Patient Financial Policy Documents

Trending on AJMC

AI Chatbots Score Below 28% on Colorectal Cancer Questions

5 Notable FDA Approvals From the First Half of 2026

New Survey Highlights Quality-of-Life Benefits of Dry Eye Disease Treatment

JAK Inhibitors Reshaped Alopecia Areata Care, but Long-Term Data Gaps Remain

Michigan Cyclospora Outbreak Surpasses 1500 Cases as Investigation Continues

Access, Affordability, & Accountability: A New Era in Oncology Reimbursement

Goals and Objectives

Articles in this issue

Related Content

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

Readability of Hospital Patient Financial Policy Documents

Trending on AJMC

AI Chatbots Score Below 28% on Colorectal Cancer Questions

5 Notable FDA Approvals From the First Half of 2026

New Survey Highlights Quality-of-Life Benefits of Dry Eye Disease Treatment

JAK Inhibitors Reshaped Alopecia Areata Care, but Long-Term Data Gaps Remain

Michigan Cyclospora Outbreak Surpasses 1500 Cases as Investigation Continues